Autobio Diagnostics Co., Ltd.

Shanghai Stock Exchange 603658.SS

Autobio Diagnostics Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 1.08

Autobio Diagnostics Co., Ltd. Revenue Per Share is USD 1.08 for the year ending December 31, 2023, a -2.09% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Autobio Diagnostics Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 1.10, a 9.07% change year over year.
  • Autobio Diagnostics Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 1.01, a 23.65% change year over year.
  • Autobio Diagnostics Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.82, a 16.02% change year over year.
  • Autobio Diagnostics Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.70, a 37.08% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
Shanghai Stock Exchange: 603658.SS

Autobio Diagnostics Co., Ltd.

CEO Mr. Rui Kuan Fang
IPO Date Sept. 2, 2016
Location China
Headquarters No. 199, 15th Avenue
Employees 5,539
Sector Health Care
Industries
Description

Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products AutoLumo A2000 Plus, an automatic Chemiluminescence immunoassay analyzer; automatic microplate chemiluminescent enzyme immunoassay; and LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Its microbiology products comprise automated blood culture systems; blood culture bottles; AUTOMIC strips; and mycoplasma IES. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is based in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Auto Industrial Co., Ltd.

Similar companies

603899.SS

Shanghai M&G Stationery Inc.

USD 3.92

1.92%

603939.SS

Yifeng Pharmacy Chain Co., Ltd.

USD 3.33

0.92%

600763.SS

Topchoice Medical Corporation

USD 5.73

2.34%

603833.SS

Oppein Home Group Inc.

USD 8.60

1.50%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.54

2.01%

StockViz Staff

January 15, 2025

Any question? Send us an email